Drug Profile
Tissue plasminogen activator gene therapy
Latest Information Update: 30 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Gene therapies; Vascular disorder therapies
- Mechanism of Action Plasminogen activator inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Peripheral vascular disorders
Most Recent Events
- 27 Apr 1999 New profile
- 27 Apr 1999 Preclinical development for Peripheral vascular disorders in USA (Injection)